# Biallelic PAX7 variants cause a novel Satellite Cell-opathy with progressive muscle involvement resembling facioscapulohumeral muscular dystrophy

**Authors:** Massimo Ganassi, Claudia Strafella, Marco Savarese, Philipp Heher, Elise N. Engquist, Liam McGuire, Mridul Johari, Gian F. De Nicola, Anne Bigot, Vincent Mouly, Sara Bortolani, Eleonora Torchia, Mauro Monforte, Domenica Megalizzi, Andrea Sabino, Enzo Ricci, Emiliano Giardina, Peter S. Zammit, Giorgio Tasca

PMC · DOI: 10.1038/s41419-025-08358-6 · Cell Death & Disease · 2026-01-29

## TL;DR

A new muscle disorder caused by PAX7 gene variants mimics facioscapulohumeral muscular dystrophy but has a distinct genetic basis.

## Contribution

Identifies biallelic PAX7 variants as a novel cause of satellite cell-related myopathy.

## Key findings

- PAX7 variants caused upregulation of splicing factors and mitochondrial ROS in myoblasts.
- Patient's muscle pathology showed myopathic changes resembling FSHD but with distinct genetic origins.
- Findings suggest impaired satellite cell function leads to progressive muscle weakness.

## Abstract

Inherited myopathies are genetic disorders characterised by declining motor function due to progressive muscle weakening and wasting. Recently, pathogenic variants in PAX7, the master transcriptional regulator of muscle stem cells, have been associated with myopathies of variable severity, arguing for impaired satellite cell function as the main pathogenic driver. Here, we report the characterisation of two missense PAX7 variants in a patient with asymmetric, progressive muscle weakness affecting facial, upper and lower body muscles, and myopathic changes on muscle pathology. Despite this disorder closely phenocopying the clinical presentation of Facioscapulohumeral muscular dystrophy (FSHD), genetic, epigenetic and transcriptomic profiling indicated that FSHD was unlikely. However, exome sequencing revealed two heterozygous variants in PAX7: c.335 C > T, (p.Pro112Leu) and c.1328 G > A (p.Cys443Tyr). Modelling these PAX7 variants in human myoblasts resembled the transcriptomic findings found in the muscle biopsy from the patient. Specifically, these PAX7 variants caused upregulation of splicing factors, an increase in mitochondrial reactive oxygen species levels and reduced cell proliferation. The phenotypic cell changes caused by the PAX7 variants support a pathomechanism whereby diminished satellite cell function impairs muscle homoeostasis. Together, multimodal investigation suggests that these variants in PAX7 are likely causative of an FSHD-like autosomal recessive myopathy and expand the spectrum of neuromuscular disorders originating from impaired satellite cell function.

## Linked entities

- **Genes:** PAX7 (paired box 7) [NCBI Gene 5081]
- **Diseases:** Facioscapulohumeral muscular dystrophy (MONDO:0001347)

## Full-text entities

- **Genes:** LRIF1 (ligand dependent nuclear receptor interacting factor 1) [NCBI Gene 55791] {aka C1orf103, FSHD3, HBiX1, RIF1}, SRSF5 (serine and arginine rich splicing factor 5) [NCBI Gene 6430] {aka HRS, SFRS5, SRP40}, MEF2C (myocyte enhancer factor 2C) [NCBI Gene 4208] {aka C5DELq14.3, DEL5q14.3, NEDHSIL}, DDX17 (DEAD-box helicase 17) [NCBI Gene 10521] {aka P72, RH70}, DR1 (down-regulator of transcription 1) [NCBI Gene 1810] {aka NC2, NC2-BETA, NC2B, NCB2}, Myhc (myosin heavy chain, cardiac muscle complex) [NCBI Gene 111671], RB1 (RB transcriptional corepressor 1) [NCBI Gene 5925] {aka OSRC, PPP1R130, RB, p105-Rb, p110-RB1, pRb}, MIF (macrophage migration inhibitory factor) [NCBI Gene 4282] {aka GIF, GLIF, MMIF}, SMCHD1 (structural maintenance of chromosomes flexible hinge domain containing 1) [NCBI Gene 23347] {aka BAMS, FSHD2}, Myh7 (myosin, heavy polypeptide 7, cardiac muscle, beta) [NCBI Gene 140781] {aka B-MHC, MYH-beta/slow, MyHC-I, Myhc-b, Myhcb, beta-MHC}, FSHMD1A (facioscapulohumeral muscular dystrophy 1A) [NCBI Gene 2489] {aka FMD, FSHD, FSHD1A, FSHMD}, MYH6 (myosin heavy chain 6) [NCBI Gene 4624] {aka ASD3, CMD1EE, CMH14, MYHC, MYHCA, SSS3}, CLEC14A (C-type lectin domain containing 14A) [NCBI Gene 161198] {aka C14orf27, CEG1, EGFR-5}, MYOD1 (myogenic differentiation 1) [NCBI Gene 4654] {aka CMYO17, CMYP17, MYF3, MYOD, MYODRIF, PUM}, PAX5 (paired box 5) [NCBI Gene 5079] {aka ALL3, BSAP, PAX-5}, DUX4 (double homeobox 4) [NCBI Gene 100288687] {aka DUX4L}, PAX7 (paired box 7) [NCBI Gene 5081] {aka CMYO19, CMYP19, HUP1, MYOSCO, PAX7B, RMS2}, Pax7 (paired box 7) [NCBI Gene 18509] {aka Pax-7}, GLB1 (galactosidase beta 1) [NCBI Gene 2720] {aka EBP, ELNR1, MPS4B}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, RPLP0 (ribosomal protein lateral stalk subunit P0) [NCBI Gene 6175] {aka L10E, LP0, P0, PRLP0, RPP0, uL10}, PDGFRA (platelet derived growth factor receptor alpha) [NCBI Gene 5156] {aka CD140A, PDGFR-2, PDGFR2}, Cdkn1a (cyclin dependent kinase inhibitor 1A) [NCBI Gene 12575] {aka CAP20, CDKI, CIP1, Cdkn1, P21, SDI1}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, Mef2c (myocyte enhancer factor 2C) [NCBI Gene 17260] {aka 5430401D19Rik, 9930028G15Rik, Mef2}, TENT5C (terminal nucleotidyltransferase 5C) [NCBI Gene 54855] {aka FAM46C}, Myh8 (myosin, heavy polypeptide 8, skeletal muscle, perinatal) [NCBI Gene 17885] {aka 4832426G23Rik, MHCp, MyHC-pn, Myhs-p, Myhsp}, CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029] {aka ARF, CAI2, CDK4I, CDKN2, CMM2, INK4}, CXCR4 (C-X-C motif chemokine receptor 4) [NCBI Gene 7852] {aka CD184, D2S201E, FB22, HM89, HSY3RR, LCR1}, PAX6 (paired box 6) [NCBI Gene 5080] {aka AN, AN1, AN2, ASGD5, D11S812E, FVH1}, LOC105243590 (Ig heavy chain Mem5-like) [NCBI Gene 105243590] {aka IgH, Igg1}, RBFOX2 (RNA binding fox-1 homolog 2) [NCBI Gene 23543] {aka FOX2, Fox-2, HNRBP2, HRNBP2, RBM9, RTA}, ND3 (NADH dehydrogenase subunit 3) [NCBI Gene 4537] {aka MTND3}, Cdkn2a (cyclin dependent kinase inhibitor 2A) [NCBI Gene 12578] {aka ARF-INK4a, Arf, INK4a-ARF, Ink4a/Arf, MTS1, Pctr1}, Myh3 (myosin, heavy polypeptide 3, skeletal muscle, embryonic) [NCBI Gene 17883] {aka MyHC-emb, Myhs-e, Myhse}, PAX3 (paired box 3) [NCBI Gene 5077] {aka CDHS, HUP2, PAX-3, WS1, WS3}, Myh2 (myosin, heavy polypeptide 2, skeletal muscle, adult) [NCBI Gene 17882] {aka MHC2A, MyHC-2a, MyHC-IIa, Myh2a, Myhs-f, Myhs-f1}, DNMT3B (DNA methyltransferase 3 beta) [NCBI Gene 1789] {aka FSHD4, ICF, ICF1, M.HsaIIIB}
- **Diseases:** mitochondrial dysfunction (MESH:D028361), extensor hallucis longus (MESH:D009127), NAM (MESH:C538343), GT (MESH:D013915), congenital scoliosis (MESH:D012600), wasting (MESH:D019282), difficulties in finger extension (MESH:D000079822), rhabdomyosarcoma (MESH:D012208), hyperCKemia (OMIM:123320), dysmorphic facial (MESH:C565579), diseases affecting muscle (MESH:D009220), Muscular dystrophies (MESH:D009136), spine deformities (MESH:D016135), skeletal muscle diseases (MESH:D005207), hypotrophy of scapular girdle (MESH:C566638), neuromuscular diseases (MESH:D009468), Myopathic conditions (MESH:D009135), vertebral malformations (MESH:C535781), muscle damage (MESH:D009133), toxicity (MESH:D064420), congenital myopathy (MESH:D009224), Inherited myopathies (MESH:D030342), ET (MESH:D016751), atrophy (MESH:D001284), fatty (MESH:D008067), Asymmetric muscle weakness (MESH:D018908), Necrotising Autoimmune Myopathy (MESH:D019283), muscle (MESH:D019042), orofacial clefting (MESH:C566121), weakness of finger and wrist extensors (MESH:D000092503), RD (MESH:D000077733), tendon contractures (MESH:D003286), muscle fibre degeneration (MESH:D000071075), FSHD (MESH:D020391), immune-mediated (MESH:C567355), MS (MESH:D009103), necrotic (MESH:D009336), impaired myogenesis (MESH:D060825), muscle involvement (MESH:C566343)
- **Chemicals:** Alexa Fluor 488 (MESH:C000711379), Alexa Fluor 350 (MESH:C400304), agarose (MESH:D012685), Amino acid (MESH:D000596), MitoTracker Deep Red (-), silica (MESH:D012822), EdU (MESH:C022811), Cysteine (MESH:D003545), Alexa Fluor 647 (MESH:C569686), Doxorubicin (MESH:D004317), puromycin (MESH:D011691), citric acid (MESH:D019343), paraformaldehyde (MESH:C003043), triton X100 (MESH:D017830), Gentamycin (MESH:D005839), Hoechst 33342 (MESH:C017807), polystyrene (MESH:D011137), polyA (MESH:D011061), eosin (MESH:D004801), H&amp;E (MESH:D006371), Tyrosine (MESH:D014443), ROS (MESH:D017382), PBS (MESH:D007854), haematoxylin (MESH:D006416), Trypan Blue (MESH:D014343)
- **Species:** Danio rerio (leopard danio, species) [taxon 7955], Gallus gallus (bantam, species) [taxon 9031], Mycoplasma (genus) [taxon 2093], Pan paniscus (bonobo, species) [taxon 9597], Rattus norvegicus (brown rat, species) [taxon 10116], Sus scrofa (pig, species) [taxon 9823], Mus musculus (house mouse, species) [taxon 10090], Ornithorhynchus anatinus (duck-billed platypus, species) [taxon 9258], Homo sapiens (human, species) [taxon 9606], Loxodonta africana (African bush elephant, species) [taxon 9785]
- **Mutations:** P306L, N267K, R56C, G459D, c.1328 G > A, C443, Proline-to-Leucine, p.Pro112Leu, C443Y, G463S, c.1328 G > A, Cysteine 443, c.1238 G > A, A282V, p.Cys443Tyr, Y495 T, V454M
- **Cell lines:** HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), AB1190 — Homo sapiens (Human), Menkes disease, Finite cell line (CVCL_1L35)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12876871/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12876871/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC12876871/full.md

---
Source: https://tomesphere.com/paper/PMC12876871